182 related articles for article (PubMed ID: 23244352)
1. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark.
Olsen J; Jørgensen TR; Kofoed K; Larsen HK
BMC Public Health; 2012 Dec; 12():1082. PubMed ID: 23244352
[TBL] [Abstract][Full Text] [Related]
2. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.
Choi I; Lee D; Son KB; Bae S
BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.
Ong KJ; Checchi M; Burns L; Pavitt C; Postma MJ; Jit M
Sex Transm Infect; 2019 Feb; 95(1):28-35. PubMed ID: 30674687
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
Sand FL; Munk C; Jensen SM; Svahn MF; Frederiksen K; Kjær SK
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1090-7. PubMed ID: 27358257
[TBL] [Abstract][Full Text] [Related]
5. The economic burden of human papillomavirus-related precancers and cancers in Sweden.
Östensson E; Silfverschiöld M; Greiff L; Asciutto C; Wennerberg J; Lydrup ML; Håkansson U; Sparén P; Borgfeldt C
PLoS One; 2017; 12(6):e0179520. PubMed ID: 28651012
[TBL] [Abstract][Full Text] [Related]
6. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study.
Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK
Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
Mpunga T; Chantal Umulisa M; Tenet V; Rugwizangoga B; Milner DA; Munyanshongore C; Heideman DAM; Bleeker MCG; Tommasino M; Franceschi S; Baussano I; Gheit T; Sayinzoga F; Clifford GM
Int J Cancer; 2020 Mar; 146(6):1514-1522. PubMed ID: 31173641
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of noncervical human papillomavirus disease in the United States.
Hu D; Goldie S
Am J Obstet Gynecol; 2008 May; 198(5):500.e1-7. PubMed ID: 18455524
[TBL] [Abstract][Full Text] [Related]
9. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
11. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
Matsuo K; Blake EA; Machida H; Mandelbaum RS; Roman LD; Wright JD
Gynecol Oncol; 2018 Sep; 150(3):501-508. PubMed ID: 30054103
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus-related anogenital premalignancies and cancer in renal transplant recipients: A Danish nationwide, registry-based cohort study.
Reinholdt K; Thomsen LT; Dehlendorff C; Larsen HK; Sørensen SS; Haedersdal M; Kjaer SK
Int J Cancer; 2020 May; 146(9):2413-2422. PubMed ID: 31291470
[TBL] [Abstract][Full Text] [Related]
13. Risk of human papillomavirus-associated cancers among persons with AIDS.
Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
Préaud E; Largeron N
J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
[TBL] [Abstract][Full Text] [Related]
15. Familial Clustering, Second Primary Cancers and Causes of Death in Penile, Vulvar and Vaginal Cancers.
Zhang L; Hemminki O; Chen T; Zheng G; Försti A; Sundquist K; Sundquist J; Hemminki K
Sci Rep; 2019 Aug; 9(1):11804. PubMed ID: 31413311
[TBL] [Abstract][Full Text] [Related]
16. Cervical, Vaginal, and Vulvar Cancer Costs Incurred by the Medicaid Program in Publicly Insured Patients in Texas.
Fu S; Fokom Domgue J; Chan W; Zhao B; Ramondetta LM; Lairson DR
J Low Genit Tract Dis; 2019 Apr; 23(2):102-109. PubMed ID: 30907776
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140
[TBL] [Abstract][Full Text] [Related]
18. Determination of Oncogenic Human Papillomavirus (HPV) Genotypes in Anogenital Cancers in Myanmar.
Mu Mu Shwe ; Hlaing Myat Thu ; Khin Saw Aye ; Aye Aye Myint ; Mya Thida ; Khin Shwe Mar ; Khin Khin Oo ; Khin Sandar Aye ; Okada S; Kyaw Zin Thant
Acta Med Okayama; 2016; 70(2):103-10. PubMed ID: 27094835
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Gilbert DC; Wakeham K; Langley RE; Vale CL
Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana.
Rantshabeng PS; Moyo S; Moraka NO; Ndlovu A; MacLeod IJ; Gaseitsiwe S; Kasvosve I
BMC Infect Dis; 2017 Nov; 17(1):731. PubMed ID: 29178840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
